Get the Stockscreener App
23.06
3.92%
-0.94
Lifemd Inc stock is traded at $23.06, with a volume of 9,378.
It is down -3.92% in the last 24 hours and up +3.17% over the past month.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
See More
Previous Close:
$24.00
Open:
$23.35
24h Volume:
9,378
Relative Volume:
4.08
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.17%
1M Performance:
+3.17%
6M Performance:
-3.92%
1Y Performance:
-11.31%
1-Day Range:
$22.34
$23.75
1-Week Range:
$22.34
$24.00
52-Week Range:
$18.50
$25.30
Lifemd Inc Stock (LFMDP) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
866 351 5907
Address
236 Fifth Avenue, Suite 400, New York
Compare LFMDP vs HITI, PETS, POM, HKPD, SCNX
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFMDP
Lifemd Inc
|
23.06 | 0 | 0 | 0 | 0 | 0.00 |
HITI
High Tide Inc
|
2.31 | 203.04M | 452.61M | -35.30M | 13.25M | -0.3863 |
PETS
Petmed Express Inc
|
2.29 | 49.01M | 182.67M | -64.87M | -22.92M | -3.1193 |
POM
Pomdoctor Ltd Adr
|
0.2447 | 29.17M | 0 | 0 | 0 | 0.00 |
HKPD
Cellyan Biotechnology Co Ltd
|
0.569 | 13.37M | 0 | 0 | 0 | 0.00 |
SCNX
Scienture Holdings Inc
|
0.2963 | 12.04M | 653.40K | -20.19M | -11.11M | -1.8091 |
Lifemd Inc Stock (LFMDP) Latest News
LifeMD Earnings Call Highlights Aggressive Growth Push - TipRanks
LifeMD, Inc. (LFMDP) Stock Price, News, Quote & History - Yahoo! Finance Canada
LFMDP SEC FilingsLifemd, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
200,000 LifeMD (LFMD) RSUs awarded to marketing head - Stock Titan
[Form 3] LifeMD, Inc. Initial Statement of Beneficial Ownership - Stock Titan
LifeMD (LFMD) CFO Atul Kavthekar listed as reporting person in Form 3 - Stock Titan
LifeMD launches Wegovy subscription program with Novo Nordisk By Investing.com - Investing.com South Africa
LifeMD Offers Novo Nordisk's Industry-First Wegovy Telehealth Subscription Program - Bitget
Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan - Benzinga
NVO: Novo Nordisk's Wegovy Subscription Program Launches with Li - GuruFocus
LifeMD launches Wegovy subscription program with Novo Nordisk - Investing.com
LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program - GlobeNewswire
Up to $1,200 off Wegovy: LifeMD launches Novo telehealth plan - Stock Titan
Novo to sell Wegovy subscriptions on Hims, LifeMD, and others - Seeking Alpha
Earnings Miss: Why is LifeMD Inc stock going up2026 Risk Factors & Breakout Confirmation Trade Signals - baoquankhu1.vn
LifeMD Offers Novo Nordisk’s Ozempic For $499 A Month To Eligible Patients - MSN
LifeMD: Comparing The High Yield Preferred Stock To An Options Income Strategy (LFMD) - Seeking Alpha
LifeMD, Inc. 8.875% CUM PFD A declares $0.5547 dividend - MSN
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - Sahm
How Lifemd Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) Affects Rotational Strategy Timing - Stock Traders Daily
LFMD Technical Analysis | Trend, Signals & Chart Patterns | LIFEMD INC (NASDAQ:LFMD) - ChartMill
Hims & Hers Expands Integrated Digital Healthcare Ecosystem - tradingview.com
[144] LifeMD, Inc. SEC Filing - Stock Titan
LifeMD appoints Atul Kavthekar as CFO - MSN
If You Invested $1,000 in Lifemd, Inc. (LFMDP) - Stock Titan
If You Invested $1,000 in Lifemd Inc (LFMD) - Stock Titan
LifeMD appoints new CFO; shares up - MSN
How The LifeMD (LFMD) Story Is Shifting On GLP‑1 Growth And Higher 2026 Targets - Yahoo Finance
LifeMD Appoints Atul Kavthekar as CFO and Expands Leadership Team to Drive AI-First Healthcare Growth 1 - Minichart
LifeMD Announces CFO Transition and Expanded Leadership Team - TipRanks
LifeMD (NASDAQ: LFMD) installs new CFO and expands leadership team - Stock Titan
LifeMD (LFMD) to Participate in B. Riley's Virtual Meeting on Ma - gurufocus.com
Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD), Immatics (IMTX) and BrightSpring Health Services, Inc. (BTSG) - The Globe and Mail
LifeMD, Inc. (NASDAQ:LFMD) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
LifeMD names Atul Kavthekar as CFO, announces leadership changes By Investing.com - Investing.com India
LifeMD, Inc. Announces Chief Financial Officer Changes - marketscreener.com
Lifemd, Inc. Announces Executive Appointments - marketscreener.com
LifeMD shares are trading higher after the co... - Benzinga
LifeMD Inc announced appointment of Atul Kavthekar as chief financial officer - marketscreener.com
LifeMD names Atul Kavthekar as CFO, announces leadership changes - Investing.com
LifeMD (NASDAQ:LFMD) Raised to Outperform at Mizuho - MarketBeat
LifeMD Inc Announced Appointment Of Atul Kavthekar As Chief Financial Officer - TradingView
LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team - GlobeNewswire
This Upstart Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Benzinga
Mizuho Upgrades LifeMD (LFMD) with Raised Price Target to $8.00 - GuruFocus
Mizuho upgrades LifeMD stock rating on weight-loss outlook By Investing.com - Investing.com Australia
Mizuho upgrades LifeMD stock rating on weight-loss outlook - Investing.com Nigeria
LifeMD outlines $250M+ annualized revenue run rate target by Q4 2026 amid record GLP-1 demand and expanded partnerships - MSN
Lifemd Inc Stock (LFMDP) Financials Data
There is no financial data for Lifemd Inc (LFMDP). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
11.51%
1.13%
Cap:
|
Volume (24h):